Novartis AG
Market Cap
270B
Short interest (May 15)
0.2%
Net Short (Jun 03 ): 0.0%
Borrow Fee
0.33%
↓ 12.4%
Available Shares
70K
↓ 65.8%
Price Chart
Company Overview
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.